J.Jpn. Surg. Soc.. 97(2): 165-171, 1996

---

Feature topic

CLINICAL VALUE OF CARBOHYDRATE ANTIGENS, SIALY LEWIS-x AND SIALY LEWIS-A IN GASTROINTESTINAL CANCER

To evaluate clinical importance of the expression of sialy Lewis-X (sLe^x) and sialyl Lewis-a antigen (sLe^a) in gastrointestillal cancers, we examined immunohistohemically expression of the two antigens in esophageal, gastric, colorectal, and pancreatic cancer. Expression of sLe^x and sLe^a were associated with several clinicopathologic features which reflect tumor aggressiveness in esophageal, gastric and colorectal cancer, but not in pancreatic cancer. In esophageal and colorectal cancer, survival rate of the patients with sLe^x positive tumors was significantly poorer than that of the patients with sLe^x negative tumors, while in gastric cancer that with sLe^a positive tumors was significantly poorer than that with sLe^a negative. Cox’s multivariate analysis revealed that sLe^x expression status was one of the significant discriminants of prognosis in colorectal cancer patients and sLe^a status in gastric cancer patients. These results suggest that sLe^x and sLe^a expression could be involved in aggresiveness of gastrointestinal cancer and might prove to be a potent marker for prognosis in patients with gastric cancer and colorectal cancer.

---

---

To read the PDF file you will need Adobe Reader installed on your computer.